Age-related differences in disease characteristics and clinical outcomes in polycythemia vera.
about
Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factorsPolycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FNew Therapeutic Approaches in Polycythemia VeraWhole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera.Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.Splanchnic vein thrombosis in myeloproliferative neoplasms.Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options.Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera.Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender.Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.
P2860
Q26777265-B9936594-3744-4D87-BD98-A91EFA93DD9CQ26795666-B0959955-1F2D-4A17-87C8-0520EEA250ADQ26795677-119F3E8D-75EE-4DAA-AFFB-D3CDE1423B95Q33582246-6AA92E4E-AAFA-4894-AD79-978A8414E97CQ37638779-63D15BD5-CB04-431C-8A3A-47A22ACFE1F1Q38121635-5C0DA395-F10E-4CA5-AD09-E468B1A4FA01Q38255717-3403D484-BD19-428A-9F2C-DC76DEEFB7B6Q38420817-7B551677-F0AC-4620-9FC6-FA6BF86676D5Q38774457-22E60FD9-D210-4C5B-957F-6A0B9B3F458EQ48163043-978E92E0-A861-40A2-9165-FEA9E540CD77Q49834761-547CFD19-958C-44D4-ABC0-633D9B7A3BFFQ49978793-0C1B6C91-6189-4D2E-9E7C-DAD8D0486F3AQ54329508-6B5B400B-1454-4F8D-870A-67C284BBA69D
P2860
Age-related differences in disease characteristics and clinical outcomes in polycythemia vera.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Age-related differences in dis ...... outcomes in polycythemia vera.
@en
Age-related differences in dis ...... outcomes in polycythemia vera.
@nl
type
label
Age-related differences in dis ...... outcomes in polycythemia vera.
@en
Age-related differences in dis ...... outcomes in polycythemia vera.
@nl
prefLabel
Age-related differences in dis ...... outcomes in polycythemia vera.
@en
Age-related differences in dis ...... outcomes in polycythemia vera.
@nl
P2093
P2860
P1433
P1476
Age-related differences in dis ...... outcomes in polycythemia vera.
@en
P2093
Alfred Rademaker
Alison R Moliterno
Anaadriana Zakarija
Anna Halpern
Brady L Stein
Brandon McMahon
Damiano Rondelli
Jamile Shammo
Jerry L Spivak
Laura Michaelis
P2860
P304
P356
10.3109/10428194.2012.759656
P577
2013-01-08T00:00:00Z